FDA approves acalabrutinib with bendamustine and rituximab for previously untreated mantle cell lymphoma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-acalabrutinib-bendamustine-and-rituximab-previously-untreated-mantle-cell-lymphoma?utm_medium=email&utm_source=govdelivery